COnventional Vs. Optimised PERiprocedural Analgosedation Vs. Total IntraVEnous Anaesthesia for Pulsed-Field Ablation (COOPERATIVE-PFA)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 127 participants.

Also called NCT06013345

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 127 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06013345
Other papers using this trial's data
  • COOPERATIVE-PFA: A Three-Arm Randomized Controlled Trial Circulation, 2025-07-22 DOI, PubMed 40287932, PMC12272916 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06013345. Randomized; single masking; primary purpose treatment. Start 2023-10-25 (actual); primary completion 2024-09-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
COnventional Vs. Optimised PERiprocedural Analgosedation Vs. Total IntraVEnous Anaesthesia for Pulsed-Field Ablation (COOPERATIVE-PFA)
Intervention (Drug)
Remimazolam
Intervention (Drug)
Propofol
Intervention (Drug)
Propofol
Lead sponsor
Charles University, Czech Republic (class: other)

Record details

Record id
cardio:ct-nct06013345
Content hash
99ee167711940bbe9f570951ce59bb203034660685ca873a929872824da5e9bd